0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rabies Vaccine Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-34M23
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Rabies Vaccine Market Insights and Forecast to 2028

Global Rabies Vaccine Market Insights and Forecast to 2028

Code: QYRE-Auto-34M23
Report
January 2022
88 Pages
QYResearch
Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Market Analysis and Insights: Global Rabies Vaccine Market

Due to the COVID-19 pandemic, the global Rabies Vaccine market size is estimated to be worth US$ 971.4 million in 2022 and is forecast to a readjusted size of US$ 1229.1 million by 2028 with a CAGR of 4.0% during the review period.

Fully considering the economic change by this health crisis, Vero Cell Rabies Vaccine accounting for % of the Rabies Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Pre-exposure Prophylaxis segment is altered to an % CAGR throughout this forecast period.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Global Rabies Vaccine Scope and Segment
Rabies Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application

Pre-exposure Prophylaxis
Post-exposure Prophylaxis

BY COMPANY

GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rabies Vaccine Sales by Region
2.4.1 Global Rabies Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Rabies Vaccine by Region (2023-2028)
2.5 Global Rabies Vaccine Revenue by Region
2.5.1 Global Rabies Vaccine Revenue by Region (2017-2022)
2.5.2 Global Rabies Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rabies Vaccine Sales by Manufacturers
3.1.1 Global Top Rabies Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Vaccine in 2021
3.2 Global Rabies Vaccine Revenue by Manufacturers
3.2.1 Global Rabies Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Vaccine Revenue in 2021
3.3 Global Rabies Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rabies Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Vaccine Sales by Type
4.1.1 Global Rabies Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Rabies Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Rabies Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Rabies Vaccine Revenue by Type
4.2.1 Global Rabies Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Rabies Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Rabies Vaccine Price by Type
4.3.1 Global Rabies Vaccine Price by Type (2017-2022)
4.3.2 Global Rabies Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rabies Vaccine Sales by Application
5.1.1 Global Rabies Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Rabies Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Rabies Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Rabies Vaccine Revenue by Application
5.2.1 Global Rabies Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Rabies Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Rabies Vaccine Price by Application
5.3.1 Global Rabies Vaccine Price by Application (2017-2022)
5.3.2 Global Rabies Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rabies Vaccine Market Size by Type
6.1.1 North America Rabies Vaccine Sales by Type (2017-2028)
6.1.2 North America Rabies Vaccine Revenue by Type (2017-2028)
6.2 North America Rabies Vaccine Market Size by Application
6.2.1 North America Rabies Vaccine Sales by Application (2017-2028)
6.2.2 North America Rabies Vaccine Revenue by Application (2017-2028)
6.3 North America Rabies Vaccine Market Size by Country
6.3.1 North America Rabies Vaccine Sales by Country (2017-2028)
6.3.2 North America Rabies Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Rabies Vaccine Market Size by Type
7.1.1 Europe Rabies Vaccine Sales by Type (2017-2028)
7.1.2 Europe Rabies Vaccine Revenue by Type (2017-2028)
7.2 Europe Rabies Vaccine Market Size by Application
7.2.1 Europe Rabies Vaccine Sales by Application (2017-2028)
7.2.2 Europe Rabies Vaccine Revenue by Application (2017-2028)
7.3 Europe Rabies Vaccine Market Size by Country
7.3.1 Europe Rabies Vaccine Sales by Country (2017-2028)
7.3.2 Europe Rabies Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccine Market Size by Type
8.1.1 Asia Pacific Rabies Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Rabies Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Rabies Vaccine Market Size by Application
8.2.1 Asia Pacific Rabies Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Rabies Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Rabies Vaccine Market Size by Region
8.3.1 Asia Pacific Rabies Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Rabies Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Rabies Vaccine Market Size by Type
9.1.1 Latin America Rabies Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Rabies Vaccine Revenue by Type (2017-2028)
9.2 Latin America Rabies Vaccine Market Size by Application
9.2.1 Latin America Rabies Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Rabies Vaccine Revenue by Application (2017-2028)
9.3 Latin America Rabies Vaccine Market Size by Country
9.3.1 Latin America Rabies Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Rabies Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rabies Vaccine Market Size by Type
10.1.1 Middle East and Africa Rabies Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rabies Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Rabies Vaccine Market Size by Application
10.2.1 Middle East and Africa Rabies Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rabies Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Rabies Vaccine Market Size by Country
10.3.1 Middle East and Africa Rabies Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rabies Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK (Novartis)
11.1.1 GSK (Novartis) Corporation Information
11.1.2 GSK (Novartis) Overview
11.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK (Novartis) Recent Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Corporation Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Pasteur Recent Developments
11.3 Chengda
11.3.1 Chengda Corporation Information
11.3.2 Chengda Overview
11.3.3 Chengda Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengda Recent Developments
11.4 Yisheng
11.4.1 Yisheng Corporation Information
11.4.2 Yisheng Overview
11.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Yisheng Recent Developments
11.5 Prcmise
11.5.1 Prcmise Corporation Information
11.5.2 Prcmise Overview
11.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Prcmise Recent Developments
11.6 VACN
11.6.1 VACN Corporation Information
11.6.2 VACN Overview
11.6.3 VACN Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 VACN Recent Developments
11.7 Changsheng
11.7.1 Changsheng Corporation Information
11.7.2 Changsheng Overview
11.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changsheng Recent Developments
11.8 BCHT
11.8.1 BCHT Corporation Information
11.8.2 BCHT Overview
11.8.3 BCHT Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BCHT Recent Developments
11.9 Hissen
11.9.1 Hissen Corporation Information
11.9.2 Hissen Overview
11.9.3 Hissen Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hissen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Vaccine Industry Chain Analysis
12.2 Rabies Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Vaccine Production Mode & Process
12.4 Rabies Vaccine Sales and Marketing
12.4.1 Rabies Vaccine Sales Channels
12.4.2 Rabies Vaccine Distributors
12.5 Rabies Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rabies Vaccine Industry Trends
13.2 Rabies Vaccine Market Drivers
13.3 Rabies Vaccine Market Challenges
13.4 Rabies Vaccine Market Restraints
14 Key Findings in The Global Rabies Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Vero Cell Rabies Vaccine
    Table 3. Major Manufacturers of BHK
    Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine
    Table 5. Major Manufacturers of Others
    Table 6. Global Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Rabies Vaccine Sales by Region (2017-2022) & (K Units)
    Table 9. Global Rabies Vaccine Sales Market Share by Region (2017-2022)
    Table 10. Global Rabies Vaccine Sales by Region (2023-2028) & (K Units)
    Table 11. Global Rabies Vaccine Sales Market Share by Region (2023-2028)
    Table 12. Global Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Rabies Vaccine Revenue Market Share by Region (2017-2022)
    Table 14. Global Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Rabies Vaccine Revenue Market Share by Region (2023-2028)
    Table 16. Global Rabies Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Rabies Vaccine Sales Share by Manufacturers (2017-2022)
    Table 18. Global Rabies Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Rabies Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 20. Rabies Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2021)
    Table 23. Rabies Vaccine Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Rabies Vaccine Product Offered
    Table 25. Date of Manufacturers Enter into Rabies Vaccine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 28. Global Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 29. Global Rabies Vaccine Sales Share by Type (2017-2022)
    Table 30. Global Rabies Vaccine Sales Share by Type (2023-2028)
    Table 31. Global Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Rabies Vaccine Revenue Share by Type (2017-2022)
    Table 34. Global Rabies Vaccine Revenue Share by Type (2023-2028)
    Table 35. Rabies Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Rabies Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 38. Global Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 39. Global Rabies Vaccine Sales Share by Application (2017-2022)
    Table 40. Global Rabies Vaccine Sales Share by Application (2023-2028)
    Table 41. Global Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Rabies Vaccine Revenue Share by Application (2017-2022)
    Table 44. Global Rabies Vaccine Revenue Share by Application (2023-2028)
    Table 45. Rabies Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Rabies Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 48. North America Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 49. North America Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 52. North America Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 53. North America Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 56. North America Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 57. North America Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Rabies Vaccine Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Rabies Vaccine Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Rabies Vaccine Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Rabies Vaccine Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Rabies Vaccine Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Rabies Vaccine Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Rabies Vaccine Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Rabies Vaccine Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GSK (Novartis) Corporation Information
    Table 108. GSK (Novartis) Description and Major Businesses
    Table 109. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. GSK (Novartis) Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GSK (Novartis) Recent Developments
    Table 112. Sanofi-Pasteur Corporation Information
    Table 113. Sanofi-Pasteur Description and Major Businesses
    Table 114. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Sanofi-Pasteur Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi-Pasteur Recent Developments
    Table 117. Chengda Corporation Information
    Table 118. Chengda Description and Major Businesses
    Table 119. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Chengda Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Chengda Recent Developments
    Table 122. Yisheng Corporation Information
    Table 123. Yisheng Description and Major Businesses
    Table 124. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Yisheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Yisheng Recent Developments
    Table 127. Prcmise Corporation Information
    Table 128. Prcmise Description and Major Businesses
    Table 129. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Prcmise Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Prcmise Recent Developments
    Table 132. VACN Corporation Information
    Table 133. VACN Description and Major Businesses
    Table 134. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. VACN Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. VACN Recent Developments
    Table 137. Changsheng Corporation Information
    Table 138. Changsheng Description and Major Businesses
    Table 139. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Changsheng Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Changsheng Recent Developments
    Table 142. BCHT Corporation Information
    Table 143. BCHT Description and Major Businesses
    Table 144. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. BCHT Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. BCHT Recent Developments
    Table 147. Hissen Corporation Information
    Table 148. Hissen Description and Major Businesses
    Table 149. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Hissen Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Hissen Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Rabies Vaccine Distributors List
    Table 155. Rabies Vaccine Customers List
    Table 156. Rabies Vaccine Market Trends
    Table 157. Rabies Vaccine Market Drivers
    Table 158. Rabies Vaccine Market Challenges
    Table 159. Rabies Vaccine Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rabies Vaccine Product Picture
    Figure 3. Global Rabies Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Vero Cell Rabies Vaccine Product Picture
    Figure 4. BHK Product Picture
    Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Rabies Vaccine Market Share by Application in 2021 & 2028
    Figure 8. Pre-exposure Prophylaxis
    Figure 9. Post-exposure Prophylaxis
    Figure 10. Rabies Vaccine Report Years Considered
    Figure 11. Global Rabies Vaccine Sales 2017-2028 (K Units)
    Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Rabies Vaccine Revenue 2017-2028 (US$ Million)
    Figure 14. Global Rabies Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Rabies Vaccine Sales Market Share by Region (2017-2022)
    Figure 16. Global Rabies Vaccine Sales Market Share by Region (2023-2028)
    Figure 17. North America Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Rabies Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Rabies Vaccine in the World: Market Share by Rabies Vaccine Revenue in 2021
    Figure 29. Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 31. Global Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 32. Global Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 33. Global Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 34. North America Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 35. North America Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 36. North America Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 37. North America Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 38. North America Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 39. North America Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 40. U.S. Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 43. Europe Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 45. Europe Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 47. Europe Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 48. Germany Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. France Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Rabies Vaccine Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Rabies Vaccine Revenue Share by Region (2017-2028)
    Figure 59. China Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. India Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Rabies Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Rabies Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Rabies Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Rabies Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Rabies Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Rabies Vaccine Value Chain
    Figure 87. Rabies Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Valacyclovir API Market Research Report 2022
Global Valacyclovir API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-8W11843
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Helicobacter Pylori Rapid Testing Market Research Report 2022
Global Helicobacter Pylori Rapid Testing Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-5Y11620
Wed Aug 10 00:00:00 UTC 2022

Add to Cart

Global Tuberculosis Infection Detection Kit Market Research Report 2022
Global Tuberculosis Infection Detection Kit Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-25G11469
Wed Aug 10 00:00:00 UTC 2022

Add to Cart

Global Viral Vectors Gene Therapy Market Research Report 2022
Global Viral Vectors Gene Therapy Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-23K11342
Mon Aug 08 00:00:00 UTC 2022

Add to Cart